{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:57:22Z","timestamp":1770962242016,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Major depressive disorder and associated mood syndromes are amongst the most common psychiatric disorders. To date, electroconvulsive therapy (ECT) is considered the most effective short-term treatment for patients with severe or treatment-resistant depression. In clinical practice, there is considerable variation in the ECT dosing schedule, with the number of sessions typically ranging from 6 to 12, with early antidepressant effects being predictive of increased positive outcomes. We describe here an unusual case of a female patient with severe depression who did not respond to ECT until the 11th session, after which she had shown a drastic improvement in her mental state.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 75-year-old female presented to the old age psychiatry inpatient unit with new onset dysphoric mood, anhedonia, and severe negativity. She scored 23 on the 17-item Hamilton Rating Scale for Depression (HAM-D), and was rated 6 on Clinical Global Impression severity (CGIS) by the responsible clinician. She suffered from post-natal depression fifty years ago and was successfully treated with ECT. She was therefore initiated on a course of ECT treatment. Her condition initially deteriorated, displaying features of catatonia and psychosis, unresponsive to ECT treatment or concurrent psychotropic medications. After 11th ECT session, she started to show signs of clinical improvement and returned close to her baseline mental state after a total of 17 ECT sessions. She remained well 3\u00a0months post-treatment, scoring 4 on HAM-D, Clinical Global Improvement or change (CGI-C) rated as 1 (very much improved). The diagnosis was ICD-10\u2009F32.3 severe depressive episode with psychotic symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>we describe here an unusual case of delayed response to electroconvulsive therapy in the treatment of severe depressive disorder. Studies have shown the number of acute ECT treatments to be highly variable, affected by a number of factors including treatment frequency, condition treated and its severity, the ECT technical parameters, as well as concurrent use of pharmacological treatment. This may call for re-consideration of the current ECT treatment guidelines, requiring more research to help stratify and standardize the treatment regime.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-021-03053-0","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T12:04:18Z","timestamp":1611230658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-3206","authenticated-orcid":false,"given":"Fangyue","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eladia","family":"Ruiz-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Essem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"3053_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/NDT.S198774","volume":"16","author":"D Voineskos","year":"2020","unstructured":"Voineskos D, Daskalakis ZJ, Blumberger DM. Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat. 2020;16:221\u201334 Available from: doi: 10.2147\/NDT.S198774.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"3053_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.euroneuro.2015.12.019","volume":"26","author":"CH Lin","year":"2016","unstructured":"Lin CH, Chen MC, Yang WC, Lane HY. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy. Eur Neuropsychopharmacol. 2016;26(2):225\u201333 Available from: doi: 10.1016\/j.euroneuro.2015.12.019.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"19","key":"3053_CR3","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1056\/NEJMct075234","volume":"357","author":"SH Lisanby","year":"2007","unstructured":"Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357(19):1939\u201345 Available from: doi: 10.1056\/NEJMct075234.","journal-title":"N Engl J Med"},{"key":"3053_CR4","volume-title":"Guidance on the use of electroconvulsive therapy [Internet]","author":"National Institue for Health and Care Excellence","year":"2003","unstructured":"National Institue for Health and Care Excellence. Guidance on the use of electroconvulsive therapy [Internet]. London: NICE; 2003. [updated Oct 2009]. (Clinical guideline [TA59]). Available from: www.nice.org.uk\/guidance\/ta59"},{"issue":"3","key":"3053_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/YCT.0b013e3181de6d6e","volume":"26","author":"BN Gangadhar","year":"2010","unstructured":"Gangadhar BN, Thirthalli J. Frequency of electroconvulsive therapy sessions in a course. J ECT. 2010;26(3):181\u20135 Available from: doi: 10.1097\/YCT.0b013e3181de6d6e.","journal-title":"J ECT"},{"issue":"4","key":"3053_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1192\/bjp.139.4.265","volume":"139","author":"RE Kendell","year":"1981","unstructured":"Kendell RE. The present status of electroconvulsive therapy. Br J Psychiatry. 1981;139(4):265\u201383 Available from: doi: 10.1192\/bjp.139.4.265.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"3053_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/YCT.0000000000000547","volume":"35","author":"A Hausmann","year":"2019","unstructured":"Hausmann A, Post T, Post F, Dehning J, Kemmler G, Grunze H. Efficacy of continuation\/maintenance electroconvulsive therapy in the treatment of patients with mood disorders: a retrospective analysis. J ECT. 2019;35(2):122\u20136 Available from: doi: 10.1097\/YCT.0000000000000547.","journal-title":"J ECT"},{"key":"3053_CR8","volume-title":"The ECT handbook, 3rd edition","year":"2013","unstructured":"Waite J, Easton A, editors. The ECT handbook, 3rd edition. Cambridge: Royal College of Psychiatrists; 2013."},{"issue":"2","key":"3053_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00124509-200006000-00002","volume":"16","author":"B Shapira","year":"2000","unstructured":"Shapira B, Tubi N, Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: role of treatment schedule. J ECT. 2000;16(2):97\u2013109 Available from: doi: 10.1097\/00124509-200006000-00002.","journal-title":"J ECT"},{"issue":"3","key":"3053_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00124509-200409000-00006","volume":"20","author":"KH Kho","year":"2004","unstructured":"Kho KH, Blansjaar BA, Vothknecht S, Cornelissen NMP, Koomen E, Zwinderman AH, Linszen DH. A study into predictors for the speed of response to electroconvulsive therapy. J ECT. 2004;20(3):154\u20139 Available from: doi:10.1097\/00124509-200409000-00006.","journal-title":"J ECT"},{"issue":"2","key":"3053_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1192\/bjp.2017.28","volume":"212","author":"L Van Diermen","year":"2018","unstructured":"Van Diermen L, Van den Ameele S, Kamperman AM, Sabbe BCG, Vermeulen T, Schrijvers D, Birkenhager TK. Prediction of electroconvulsive therapy response and remission in major depression: Meta-analysis. Br J Psychiatry. 2018;212(2):71\u201380 Available from: doi: 10.1192\/bjp.2017.28.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"3053_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1017\/S1461145712000806","volume":"16","author":"KL Colleen","year":"2013","unstructured":"Colleen KL, Garfield JBB, Katalinic N, Schweitzer I, Hadzi-Pavlovic D. Speed of response in ultrabrief and brief pulse width right unilateral ECT. Int J Neuropsychopharmacol. 2013;16(4):755\u201361 Available from: doi: 10.1017\/S1461145712000806.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"3053_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/acps.12251","volume":"129","author":"M Fink","year":"2014","unstructured":"Fink M. What was learned: studies by the consortium for research in ECT (CORE) 1997\u20132011. Acta Psychiatr Scand. 2014;129(6):417\u201326 Available from: doi: 10.1111\/acps.12251.","journal-title":"Acta Psychiatr Scand"},{"key":"3053_CR14","first-page":"673","volume-title":"Number of electroconvulsive therapy sessions required for Thai psychiatric patients: a retrospective study","author":"P Ittasakul","year":"2020","unstructured":"Ittasakul P, Vora-arporn S, Waleeprakhon P, Tor PC. Number of electroconvulsive therapy sessions required for Thai psychiatric patients: a retrospective study, vol. 16; 2020. p. 673\u20139. Available from: doi: 10.2147\/NDT.S244031"},{"key":"3053_CR15","doi-asserted-by":"crossref","unstructured":"Chan CYW, Abdin E, Seow E, Subramaniam M, Liu J, Peh CX. Tor PC. Clinical effectiveness and speed of response of electroconvulsive therapy in treatment-resistant schizophrenia. 2019;73(7):416\u201322 Available from: doi: 10.1111\/pcn.12855.","DOI":"10.1111\/pcn.12855"},{"issue":"4","key":"3053_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4088\/JCP.v65n0406","volume":"65","author":"MM Husain","year":"2004","unstructured":"Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry. 2004;65(4):485\u201391 Available from: doi: 10.4088\/JCP.v65n0406.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"3053_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/IJPSYM.IJPSYM_410_19","volume":"42","author":"J Thirthalli","year":"2020","unstructured":"Thirthalli J, Naik SS, Kunigiri G. Frequency and duration of course of ECT sessions: an appraisal of recent evidence. Indian J Psychol Med. 2020;42(3):207\u201318 Available from: doi:10.4103\/IJPSYM.IJPSYM_410_19.","journal-title":"Indian J Psychol Med"},{"issue":"5","key":"3053_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1440-1819.2005.01412.x","volume":"59","author":"K Tsuchiyama","year":"2005","unstructured":"Tsuchiyama K, Nagayama H, Yamada K, Isogawa K, Katsuragi S, Kiyota A. Predicting efficacy of electroconvulsive therapy in major depressive disorder. Psychiatry Clin Neurosci. 2005;59(5):546\u201350 Available from: doi: 10.1111\/j.1440-1819.2005.01412.x.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"3053_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.brs.2017.01.226","volume":"10","author":"H Maoz","year":"2017","unstructured":"Maoz H, Nitzan U, Goldwin Y, Krieger I, Bloch Y. How long should ECT course in adolescents last? A retrospective review. Brain Stimul. 2017;10(2):413 Available from: doi: 10.1016\/j.brs.2017.01.226.","journal-title":"Brain Stimul"},{"key":"3053_CR20","volume-title":"International classification of diseases for mortality and morbidity statistics (10th version)","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. International classification of diseases for mortality and morbidity statistics (10th version). 2019. Available from: https:\/\/icd.who.int\/browse10\/2019\/en"},{"issue":"5","key":"3053_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0004867417743793","volume":"52","author":"SJ Rosenman","year":"2018","unstructured":"Rosenman SJ. Electroconvulsive therapy stimulus titration: Not all it seems. Aust N Z J Psychiatry. 2018;52(5):410\u20134 Available from: doi: 10.1177\/0004867417743793.","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"3053_CR22","doi-asserted-by":"publisher","first-page":"E116","DOI":"10.3390\/ph13060116","volume":"13","author":"VL Ruberto","year":"2020","unstructured":"Ruberto VL, Jha MK, Murrough JW. Pharmacological treatments for patients with treatment-resistant depression. Pharmaceuticals (Basel). 2020;13(6):E116 Available from: doi: 10.3390\/ph13060116.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"3053_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","volume":"158","author":"RC Shelton","year":"2001","unstructured":"Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry. 2001;158(1):131\u20134 Available from: doi: 10.1176\/appi.ajp.158.1.131.","journal-title":"Am J Psychiatry"},{"key":"3053_CR24","unstructured":"Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press <http:\/\/www.medicinescomplete.com> [Accessed on [06\/12\/2020]]."},{"issue":"5","key":"3053_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/S1092852916000523","volume":"21","author":"M Solmi","year":"2016","unstructured":"Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectr. 2016;21(5):403\u201318 Available from: doi: 10.1017\/S1092852916000523.","journal-title":"CNS Spectr"},{"issue":"6","key":"3053_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/0269881119844199","volume":"33","author":"KK Goh","year":"2019","unstructured":"Goh KK, Chen CH, Chiu YH, Lu ML. Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety. J Psychopharmacol. 2019;33(6):700\u201313 Available from: doi: 10.1177\/0269881119844199.","journal-title":"J Psychopharmacol"},{"key":"3053_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/NDT.S100908","volume":"12","author":"Zolezzi","year":"2016","unstructured":"Zolezzi. Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 2016;12:931\u20139 Available from: doi: 10.2147\/NDT.S100908.","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03053-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-021-03053-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03053-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T12:09:10Z","timestamp":1611230950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03053-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3053"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03053-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish the information was obtained from the patient. A copy of written consent is available for the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}